ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
NACompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
July 31, 2003
Study Completion Date
February 28, 2007
Conditions
Peripheral Stem Cell/Marrow Transplant
Interventions
DRUG
G-CSF/Filgrastim
Trial Locations (1)
Unknown
Cross Cancer Institute, Edmonton
All Listed Sponsors
lead
Alberta Health services
OTHER
NCT00168168 - ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159 | Biotech Hunter | Biotech Hunter